Windlas Biotech Limited (NSE:WINDLAS)
1,075.80
-15.50 (-1.42%)
Oct 1, 2026, 3:30 PM IST
| Market Cap | 22.34B +17.6% |
| Revenue (ttm) | 9.42B +18.5% |
| Net Income | 664.44M +1.9% |
| EPS | 31.13 +1.2% |
| Shares Out | 20.64M |
| PE Ratio | 34.77 |
| Forward PE | n/a |
| Dividend | 6.30 (0.59%) |
| Ex-Dividend Date | Jul 16, 2026 |
| Volume | 63,775 |
| Open | 1,091.30 |
| Previous Close | 1,091.30 |
| Day's Range | 1,052.60 - 1,101.30 |
| 52-Week Range | 697.40 - 1,181.90 |
| Beta | 0.29 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 6, 2026 |